Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Net Cash Flow (2016 - 2026)

Healthequity (HQY) has 13 years of Net Cash Flow data on record, last reported at $4.8 million in Q4 2025.

  • For Q4 2025, Net Cash Flow rose 201.44% year-over-year to $4.8 million; the TTM value through Oct 2025 reached -$12.9 million, down 8.46%, while the annual FY2025 figure was -$108.0 million, 172.16% down from the prior year.
  • Net Cash Flow reached $4.8 million in Q4 2025 per HQY's latest filing, down from $16.6 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $408.0 million in Q2 2021 and bottomed at -$423.7 million in Q1 2022.
  • Average Net Cash Flow over 5 years is $495150.0, with a median of $16.1 million recorded in 2022.
  • Peak YoY movement for Net Cash Flow: surged 2077.27% in 2021, then plummeted 1538.91% in 2022.
  • A 5-year view of Net Cash Flow shows it stood at -$104.6 million in 2021, then surged by 131.84% to $33.3 million in 2022, then skyrocketed by 31.24% to $43.7 million in 2023, then tumbled by 110.82% to -$4.7 million in 2024, then skyrocketed by 201.44% to $4.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were $4.8 million in Q4 2025, $16.6 million in Q3 2025, and -$8.1 million in Q2 2025.